The main purpose of the Clinical Trial Modernization Act is to update and improve the way clinical trials are conducted in the United States. It aims to make it easier for people, especially those from underrepresented groups, to participate in these trials. This is important because diverse participation can lead to better research outcomes and more effective treatments for various health conditions. Key provisions of the Act include several initiatives to encourage participation from underrepresented populations.